22-46690006-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_022766.6(CERK):c.1527T>A(p.Pro509Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00249 in 1,607,210 control chromosomes in the GnomAD database, including 84 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 40 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 44 hom. )
Consequence
CERK
NM_022766.6 synonymous
NM_022766.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.97
Genes affected
CERK (HGNC:19256): (ceramide kinase) CERK converts ceramide to ceramide 1-phosphate (C1P), a sphingolipid metabolite. Both CERK and C1P have been implicated in various cellular processes, including proliferation, apoptosis, phagocytosis, and inflammation (Kim et al., 2006 [PubMed 16488390]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.1).
BP6
Variant 22-46690006-A-T is Benign according to our data. Variant chr22-46690006-A-T is described in ClinVar as [Benign]. Clinvar id is 777761.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.97 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0126 (1910/152008) while in subpopulation AFR AF= 0.0436 (1806/41436). AF 95% confidence interval is 0.0419. There are 40 homozygotes in gnomad4. There are 911 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 40 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CERK | NM_022766.6 | c.1527T>A | p.Pro509Pro | synonymous_variant | 12/13 | ENST00000216264.13 | NP_073603.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CERK | ENST00000216264.13 | c.1527T>A | p.Pro509Pro | synonymous_variant | 12/13 | 1 | NM_022766.6 | ENSP00000216264.8 | ||
CERK | ENST00000443629.5 | n.*905T>A | non_coding_transcript_exon_variant | 11/12 | 1 | ENSP00000400859.1 | ||||
CERK | ENST00000443629.5 | n.*905T>A | 3_prime_UTR_variant | 11/12 | 1 | ENSP00000400859.1 | ||||
CERK | ENST00000471929.1 | n.*49T>A | downstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0125 AC: 1904AN: 151890Hom.: 40 Cov.: 32
GnomAD3 genomes
AF:
AC:
1904
AN:
151890
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00354 AC: 860AN: 242930Hom.: 17 AF XY: 0.00264 AC XY: 350AN XY: 132476
GnomAD3 exomes
AF:
AC:
860
AN:
242930
Hom.:
AF XY:
AC XY:
350
AN XY:
132476
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00143 AC: 2085AN: 1455202Hom.: 44 Cov.: 31 AF XY: 0.00120 AC XY: 872AN XY: 724202
GnomAD4 exome
AF:
AC:
2085
AN:
1455202
Hom.:
Cov.:
31
AF XY:
AC XY:
872
AN XY:
724202
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0126 AC: 1910AN: 152008Hom.: 40 Cov.: 32 AF XY: 0.0123 AC XY: 911AN XY: 74332
GnomAD4 genome
AF:
AC:
1910
AN:
152008
Hom.:
Cov.:
32
AF XY:
AC XY:
911
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
14
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 21, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at